Specialty Pharmacy

The FDA today granted breakthrough therapy designation to a new treatment for non-small cell lung cancer patients.

Esbriet was granted orphan drug designation and received priority review.

Nanotechnology and shortwave infrared light reveals small tumors and cardiovascular lesions deep inside body.

Hexavalent vaccine protects against diphtheria, tetanus, pertussis, polio, invasive disease caused by Haemophilus influenzae type b, and hepatitis B.

The FDA has approved a new treatment for adults who experience bleeding episodes from a rare and potentially life-threatening form of hemophilia.

Three individuals who were in close contact with an Ebola patient have been placed under quarantine.

Diplomat CEO discusses the company's initial public offering and developing trends in the industry.

Treatment success often depends on the stage of the infection in which they are administered.

Further studies needed to evaluate sleep-related risk factors in IBD, authors say.

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.

Researchers found significant improvements in overall survival and in disease-free survival in patients who received trastuzumab in addition to chemotherapy.

Learn about the strains involved in the current and past epidemics, the features of the Ebola virus, information about aerosolized spread, and treatments in development.

Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.

Researchers identify mechanisms that trigger hematopoietic stem cell production.

Progress in the fight against an Ebola outbreak has been made on 2 fronts.

Treatment inhibits key process that enables cancer cells to multiply.

Notable outbreaks over the past 2 decades have qualified enterovirus D68 as an emerging pathogen.

Chronic inflammation may lead to development of aggressive form of cancer.

Specialty drug spending predicted to grow by more than 16% annually from 2015 to 2018.

Antiretroviral therapy provides similar benefits for stimulant users and non-users alike.

A hospital employee may have been in contact with clinical specimens from a deceased Ebola patient.

The second nurse to become infected with the Ebola virus after treating the index patient in Texas should not have been allowed to board a flight from Ohio earlier this week.

A second health care worker who tested positive for the Ebola virus traveled by air the day before her symptoms appeared.

The disease burden of smoking remains immense despite widespread tobacco cessation efforts.

SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.

Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses MedImpact's Centers of Excellence program.

Pharmacy Times and Specialty Pharmacy Times add several new organizations to Strategic Alliance Partnership programs.

Nearly 700 children across 46 states are now infected with the severe respiratory illness.

Palbociclib provides first-line systemic treatment for women with advanced or metastatic breast cancer.